These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35397932)

  • 1. Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; A practical and universal tool for management.
    van Leeuwen RWF; le Comte M; Reyners AKL; van den Tweel A; van Vlijmen B; Kwee W; Wensveen B; Steeghs N; Visser O; van Gelder T; Jansman FGA
    Semin Oncol; 2022 Apr; 49(2):119-129. PubMed ID: 35397932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions.
    van Leeuwen RWF; Jansman FGA; van den Bemt PMLA; de Man F; Piran F; Vincenten I; Jager A; Rijneveld AW; Brugma JD; Mathijssen RHJ; van Gelder T
    Ann Oncol; 2015 May; 26(5):992-997. PubMed ID: 25628444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitigating the Risk of Drug Interactions in Cancer Patients Taking Oral Anticancer Agents: The Role of a Multidisciplinary Team-Based Medication Reconciliation.
    Rodrigues J; Marques P; Gomes C; Portela C
    Cureus; 2023 Feb; 15(2):e35324. PubMed ID: 36994248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists.
    Chan A; Tan SH; Wong CM; Yap KY; Ko Y
    Clin Ther; 2009; 31 Pt 2():2379-86. PubMed ID: 20110047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Drug-Drug and Herb-Drug Interactions in Patients With Cancer: A Prospective Study of Medication Surveillance.
    Ramos-Esquivel A; Víquez-Jaikel Á; Fernández C
    J Oncol Pract; 2017 Jul; 13(7):e613-e622. PubMed ID: 28628392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-drug interactions in pediatric oncology patients.
    Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
    Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
    Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study.
    Kim SH; Suh Y; Ah YM; Jun K; Lee JY
    Support Care Cancer; 2020 Aug; 28(8):3617-3626. PubMed ID: 31802250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An International Consensus List of Potentially Clinically Significant Drug-Drug Interactions in Older People.
    Anrys P; Petit AE; Thevelin S; Sallevelt B; Drenth C; Soiza RL; Correa-Pérez A; Dalleur O; De Brauwer I; Petrovic M; Coleman JJ; Dalton K; O'Mahony D; Löwe A; Thürig S; Gudmundsson A; Cherubini A; Panos A; Mavridis D; Rodondi N; Spinewine A
    J Am Med Dir Assoc; 2021 Oct; 22(10):2121-2133.e24. PubMed ID: 33901428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions between chemotherapeutic regimens and antiepileptics.
    Yap KY; Chui WK; Chan A
    Clin Ther; 2008 Aug; 30(8):1385-407. PubMed ID: 18803983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
    Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A
    Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-drug interactions in Neonatal Intensive Care Units: how to overcome a challenge.
    Rosen K; Wiesen MH; Oberthür A; Michels G; Roth B; Fietz C; Müller C
    Minerva Pediatr (Torino); 2021 Apr; 73(2):188-197. PubMed ID: 31621271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.
    Wong CM; Ko Y; Chan A
    Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Drug-drug Interactions at a Referral Pediatric Oncology Ward in Iran: A Cross-sectional Study.
    Tavousi F; Sadeghi A; Darakhshandeh A; Moghaddas A
    J Pediatr Hematol Oncol; 2019 Apr; 41(3):e146-e151. PubMed ID: 30531601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
    Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers.
    Ko Y; Malone DC; Skrepnek GH; Armstrong EP; Murphy JE; Abarca J; Rehfeld RA; Reel SJ; Woosley RL
    Drug Saf; 2008; 31(6):525-36. PubMed ID: 18484786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid metabolism and drug-drug interaction in cancer.
    Aapro M; Fogli S; Morlion B; Danesi R
    Oncologist; 2024 May; ():. PubMed ID: 38780124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative framework and strategies for management and evaluation of metabolic drug-drug interactions in oncology drug development: new molecular entities as object drugs.
    Venkatakrishnan K; Pickard MD; von Moltke LL
    Clin Pharmacokinet; 2010 Nov; 49(11):703-27. PubMed ID: 20923246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Descriptive study of drug-drug interactions attributed to prescriptions written upon discharge from the emergency department.
    Jawaro T; Bridgeman PJ; Mele J; Wei G
    Am J Emerg Med; 2019 May; 37(5):924-927. PubMed ID: 30880039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for selecting drug-drug interactions for clinical decision support.
    Tilson H; Hines LE; McEvoy G; Weinstein DM; Hansten PD; Matuszewski K; le Comte M; Higby-Baker S; Hanlon JT; Pezzullo L; Vieson K; Helwig AL; Huang SM; Perre A; Bates DW; Poikonen J; Wittie MA; Grizzle AJ; Brown M; Malone DC
    Am J Health Syst Pharm; 2016 Apr; 73(8):576-85. PubMed ID: 27045070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.